These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23701380)

  • 21. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting activation enthalpies of cytochrome-P450-mediated hydrogen abstractions. 2. Comparison of semiempirical PM3, SAM1, and AM1 with a density functional theory method.
    Mayeno AN; Robinson JL; Yang RS; Reisfeld B
    J Chem Inf Model; 2009 Jul; 49(7):1692-703. PubMed ID: 19522482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular docking and in vitro evaluations reveal the role of human cytochrome P450 3A4 in the cross-coupling metabolism of phenolic xenobiotics.
    Liu L; Cui H; Huang Y; Yan H; Zhou Y; Wan Y
    Environ Res; 2023 Mar; 220():115256. PubMed ID: 36634892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism.
    Huang TW; Zaretzki J; Bergeron C; Bennett KP; Breneman CM
    J Chem Inf Model; 2013 Dec; 53(12):3352-66. PubMed ID: 24261543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
    Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H
    Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6.
    Martiny VY; Carbonell P; Chevillard F; Moroy G; Nicot AB; Vayer P; Villoutreix BO; Miteva MA
    Bioinformatics; 2015 Dec; 31(24):3930-7. PubMed ID: 26315915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation.
    Shukla R; Chetri PB; Sonkar A; Pakharukova MY; Mordvinov VA; Tripathi T
    J Biomol Struct Dyn; 2018 Oct; 36(13):3541-3556. PubMed ID: 29029597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the Cytochrome P450 1A2- and 3A4-Mediated Metabolism of Aflatoxin B1 in Ligand and Protein Contributions.
    Bonomo S; Jørgensen FS; Olsen L
    Chemistry; 2017 Feb; 23(12):2884-2893. PubMed ID: 28078726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
    Tarcsay Á; Keseru GM
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):299-312. PubMed ID: 21291341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
    Atkins WM
    Annu Rev Pharmacol Toxicol; 2005; 45():291-310. PubMed ID: 15832445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of protein flexibility on the site of metabolism prediction for CYP2A6 substrates.
    Sheng Y; Chen Y; Wang L; Liu G; Li W; Tang Y
    J Mol Graph Model; 2014 Nov; 54():90-9. PubMed ID: 25459760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based site of metabolism prediction for cytochrome P450 2D6.
    Moors SL; Vos AM; Cummings MD; Van Vlijmen H; Ceulemans A
    J Med Chem; 2011 Sep; 54(17):6098-105. PubMed ID: 21797232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico prediction of cytochrome P450-mediated site of metabolism (SOM).
    Liu X; Shen Q; Li J; Li S; Luo C; Zhu W; Luo X; Zheng M; Jiang H
    Protein Pept Lett; 2013 Mar; 20(3):279-89. PubMed ID: 22591483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based drug metabolism predictions for drug design.
    Sun H; Scott DO
    Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. XenoSite server: a web-available site of metabolism prediction tool.
    Matlock MK; Hughes TB; Swamidass SJ
    Bioinformatics; 2015 Apr; 31(7):1136-7. PubMed ID: 25411327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.
    Tyzack JD; Kirchmair J
    Chem Biol Drug Des; 2019 Apr; 93(4):377-386. PubMed ID: 30471192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxygen and xenobiotic reductase activities of cytochrome P450.
    Goeptar AR; Scheerens H; Vermeulen NP
    Crit Rev Toxicol; 1995; 25(1):25-65. PubMed ID: 7734059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
    Kemp CA; Flanagan JU; van Eldik AJ; Maréchal JD; Wolf CR; Roberts GC; Paine MJ; Sutcliffe MJ
    J Med Chem; 2004 Oct; 47(22):5340-6. PubMed ID: 15481972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.